Amgen Inc. (AMGN) Stock: Surge as 12% Revenue and Strong Cash Flow Attracts Investor Attention
TLDR: Amgen’s Q3 revenue hits $9.6B, with 12% growth year-over-year. Strong sales from Repatha® and TEPEZZA® boost Amgen’s performance. Amgen reports 25% increase in operating...












